Targeting hypoxia-inducible factors with 32-134D safely and effectively treats diabetic eye disease in mice is a research paper published in Journal of Clinical Investigation (2023). On theSindex it has a DataRank of 0. It has been cited 34 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Eye Institute
Grant: R01EY029750,R01EY032104,EY001765
National Institutes of Health
Grant: P30 CA006973,1S10RR026824,UL1 TR003098
TEDCO Maryland Innovation Initiative
Grant: TEDCO Maryl
TEDCO Maryland Innovation Initiative
Grant: Innovation Initiative
Research to Prevent Blindness
Grant: Special Scholar Award,Sybil B. Harrington Stein Innovation Award,unrestricted grant
CellSight
Grant: Development Fund
Doni Solich Family
Grant: Chair in Ocular Stem Cell Research
Branna and Irving Sisenwein
Grant: Professorship in Ophthalmology
NCATS NIH HHS
Grant: UL1 TR003098
NEI NIH HHS
Grant: R01 EY032104
NEI NIH HHS
Grant: R01 EY029750
NCI NIH HHS
Grant: P30 CA006973
NCRR NIH HHS
Grant: S10 RR026824
MeSH Terms
Keywords